Ryne Bio is a biotechnology company advancing off-the-shelf neuron replacement therapies as potent disease-modifying treatments for neurological disorders.

To achieve this they leverage induced pluripotent stem cell (iPSC) technology, which enables precision manufacture of therapeutically relevant human neurons.

Their lead program targeting Parkinson’s Disease is a cryopreserved iPSC dopamine neuron progenitor (RNDP-001) that can be reliably manufactured and delivered

Biotechnology

Research

Ryne Bio

Nicholas Manusos

Carter Cliff

Jeffrey Jonas

Rajesh Mistry

Anton Bittner

Valeria Yartseva

Martin Ostrowski

Howard Federoff

Ryne Bio

Org chart

Teams

Similar companies